Overview
Evgeny Tsimerinov is a Neurologist in Columbia, Maryland. Dr. Tsimerinov is rated as an Experienced provider by MediFind in the treatment of Hereditary Hyperekplexia. His top areas of expertise are Cervical Myelopathy, Dysembryoplastic Neuroepithelial Tumors (DNET), Invertebral Disc Disease, and Brain Stem Cancer.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hereditary Hyperekplexia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10275 Little Patuxent Pkwy Ste 300, Columbia, MD 21044
812 Avis Dr, Ann Arbor,, MI 48108
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Outpatient Center
Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Elite provider by MediFind in the treatment of Hereditary Hyperekplexia. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).
Olwen Murphy is a Neurologist in Baltimore, Maryland. Dr. Murphy is rated as an Advanced provider by MediFind in the treatment of Hereditary Hyperekplexia. Her top areas of expertise are Multiple Sclerosis (MS), Stiff Person Syndrome, Acute Flaccid Myelitis (AFM), and Optic Neuritis.
Johns Hopkins Outpatient Center
With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of Hereditary Hyperekplexia. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cervical MyelopathyDr. Tsimerinov isDistinguished. Learn about Cervical Myelopathy.
- Advanced
- Brain Stem CancerDr. Tsimerinov isAdvanced. Learn about Brain Stem Cancer.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- Foot DropDr. Tsimerinov isAdvanced. Learn about Foot Drop.
- Fractured SpineDr. Tsimerinov isAdvanced. Learn about Fractured Spine.
- HemangioblastomaDr. Tsimerinov isAdvanced. Learn about Hemangioblastoma.
- Invertebral Disc DiseaseDr. Tsimerinov isAdvanced. Learn about Invertebral Disc Disease.
- Experienced
- Acoustic NeuromaDr. Tsimerinov isExperienced. Learn about Acoustic Neuroma.
- Arteriovenous MalformationDr. Tsimerinov isExperienced. Learn about Arteriovenous Malformation.
- Arthrogryposis Multiplex CongenitaDr. Tsimerinov isExperienced. Learn about Arthrogryposis Multiplex Congenita.
- Arthrogryposis Multiplex Congenita Neurogenic Type
- AstrocytomaDr. Tsimerinov isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Tsimerinov isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).

